Suscribirse

The protective effect of farm milk consumption on childhood asthma and atopy: The GABRIELA study - 30/09/11

Doi : 10.1016/j.jaci.2011.07.048 
Georg Loss, MSc a, b, , Silvia Apprich, PhD c, Marco Waser, PhD a, b, Wolfgang Kneifel, PhD c, Jon Genuneit, MD d, Gisela Büchele, PhD d, Juliane Weber, MD e, Barbara Sozanska, MD f, Hanna Danielewicz, MD f, Elisabeth Horak, MD g, R.J. Joost van Neerven, PhD h, Dick Heederik, PhD i, Peter C. Lorenzen, PhD j, Erika von Mutius, MD e, Charlotte Braun-Fahrländer, MD a, b

GABRIELA study group

  The members of the GABRIELA study group are shown in Appendix 1.

a Swiss Tropical and Public Health Institute, Basel, Switzerland 
b University of Basel, Basel, Switzerland 
c BOKU Vienna, Department of Food Science and Technology, University of Natural Resources and Life Sciences, Vienna, Austria 
d Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany 
e LMU Munich, University Children’s Hospital, Munich, Germany 
f 1st Department of Paediatrics, Allergology and Cardiology, Wroclaw Medical University, Wroclaw, Poland 
g Department of Pediatrics and Adolescents, Division of Cardiology and Pulmonology, Innsbruck Medical University, Innsbruck, Austria 
h Friesland Campina Research, Deventer, The Netherlands 
i Institute for Risk Assessment Sciences (IRAS), Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands 
j Max Rubner-Institut, Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, Kiel, Germany 

Corresponding author: Georg Loss, MSc, Swiss Tropical and Public Health Institute, Socinstrasse 57, PO Box, 4002 Basel, Switzerland.

Abstract

Background

Farm milk consumption has been identified as an exposure that might contribute to the protective effect of farm life on childhood asthma and allergies. The mechanism of action and the role of particular constituents of farm milk, however, are not yet clear.

Objective

We sought to investigate the farm milk effect and determine responsible milk constituents.

Methods

In rural regions of Germany, Austria, and Switzerland, a comprehensive questionnaire about farm milk consumption and other farm-related exposures was completed by parents of 8334 school-aged children, and 7606 of them provided serum samples to assess specific IgE levels. In 800 cow’s milk samples collected at the participants’ homes, viable bacterial counts, whey protein levels, and total fat content were analyzed. Asthma, atopy, and hay fever were associated to reported milk consumption and for the first time to objectively measured milk constituents by using multiple regression analyses.

Results

Reported raw milk consumption was inversely associated to asthma (adjusted odds ratio [aOR], 0.59; 95% CI, 0.46-0.74), atopy (aOR, 0.74; 95% CI, 0.61-0.90), and hay fever (aOR, 0.51; 95% CI, 0.37-0.69) independent of other farm exposures. Boiled farm milk did not show a protective effect. Total viable bacterial counts and total fat content of milk were not significantly related to asthma or atopy. Increased levels of the whey proteins BSA (aOR for highest vs lowest levels and asthma, 0.53; 95% CI, 0.30-0.97), ⍺-lactalbumin (aOR for interquartile range and asthma, 0.71; 95% CI, 0.52-0.97), and β-lactoglobulin (aOR for interquartile range and asthma, 0.62; 95% CI, 0.39-0.97), however, were inversely associated with asthma but not with atopy.

Conclusions

The findings suggest that the protective effect of raw milk consumption on asthma might be associated with the whey protein fraction of milk.

El texto completo de este artículo está disponible en PDF.

Key words : Allergic diseases, asthma, atopy, children, farming, hay fever, microorganism, farm milk, risk, whey protein

Abbreviations used : ALP, aOR


Esquema


 Supported by a European Union Research grant under the FP6-LifeSCIHEALTH Integrated Program LSH-2004-1.2.5-1 (contract no. 018996).
 Disclosure of potential conflict of interest: J. Weber, B. Sozanska, H. Danielewicz, A Boznanski, A. Dębińska, M. Depner, A. Kosmęda, and C. Strunz-Lehner have received research support from the European Commission. D. Heederik and I. M. Wouters have received research support from the European Union. E. von Mutius is a consultant for Novartis, GlaxoSmithKline, ALK-Abelló, and Protectimmun; has received a speaker’s fee from InfectoPharm; has received research support from Airsonett AB; is a member of the Expert Panel for UK Research Excellence Framework; and is an Associate Editor for the Journal of Allergy and Clinical Immunology. M. Ege has received research support from the European Commission and the Deutsche Forschungsgemeinschaft (DFG). M. Kabesch has financial interests in Roxall, GlaxoSmithKline, Novartis, Sanofi-Aventis, Allergopharma, and AstraZeneca GmbH and has received research support from DFG, BMBF, and the European Union. The rest of the authors have declared that they have no conflict of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 128 - N° 4

P. 766 - octobre 2011 Regresar al número
Artículo precedente Artículo precedente
  • New-onset asthma and the effect of environment and occupation among farming and nonfarming rural subjects
  • Øyvind Omland, Charlotte Hjort, Ole Find Pedersen, Martin R. Miller, Torben Sigsgaard
| Artículo siguiente Artículo siguiente
  • Rising prevalence of asthma is sex-specific in a US farming population
  • Caroline A. Motika, Charalampos Papachristou, Mark Abney, Lucille A. Lester, Carole Ober

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.